AKT1 and colonic neoplasm: Our results showed that the dual inhibition of Aurora A and AKT significantly suppressed the proliferation of colon cancer cell lines HCT-15 and HCT-116, underscoring the efficacy of targeting multiple pathways simultaneously to enhance therapeutic outcomes.